MSCA Staff Exchanges involve organisations from the academic and non-academic sectors (including SMEs) from across the globe.
Support is provided for international, inter-sectoral and interdisciplinary mobility of R&I staff leading to knowledge transfer between participating organisations.
View this resource Bookmark this resourceCross-sectoral talent circulation and academia-business collaboration for knowledge transfer is requiring systematising and structuring efforts. Through ERA4You, as one of the ERA Policy Agenda outcomes[1], the European Commission aims to support and incentivise such transformations, towards a more balanced circulation of talents, both trans-nationally and across sectors. Within this scope, ERA Talents aims to support training and mobility of researchers, innovators, and other research and innovation talents across sectors with a particular focus on Widening countries.
Complementary to ERA Chairs, Excellence Hubs, ERA Fellowships and MSCA Staff Exchanges, the ERA Talents scheme promotes innovative inter-sectoral collaboration in research and innovation through cross-sectoral exchange of staff, with a focus on Widening countries. Grants awarded under this topic are expected to collaborate with each other and participate in mutual learning exercises.
Intersectoral mobility. Actions are invited to develop activities in view of realising one or more of the following European Commission’s objectives regarding intersectoral mobility. The European Commission aims at selecting a portfolio of complementary actions where possible.
View this resource Bookmark this resourceThe objective is to foster international cooperation in MSCA in Horizon Europe, through a dedicated support action to complement and ensure coordination between existing promotion channels at local level, and ensure consistency with formal R&I policy dialogues at bilateral and regional levels
View this resource Bookmark this resourcePublished by European Commission (EC)
European Open Science CloudThe aim is to provide researchers with a set of highly innovative new services via the EOSC Exchange. These would exploit, in a structural way, the cloud-based EOSC Core technologies and horizontal European compute and data management capacities that are part of the Minimum Viable EOSC platform in production.
To be customizable and scalable, all developments should be tested against 2-3 real life use cases from a variety of scientific domains. The proposals should cooperate with the EOSC Testbed facility (to be funded under HORIZON-INFRA-2023-EOSC-01-04) as well as other relevant and related projects and e-Infrastructures and large user communities. Joint use cases and testing across individual project boundaries are encouraged.
View this resource Bookmark this resourcePublished by European Commission (EC)
European Open Science CloudThe aim is to provide researchers with a set of highly innovative new services via the EOSC Exchange. These would exploit, in a structural way, the cloud-based EOSC Core technologies and horizontal European compute and data management capacities that are part of the Minimum Viable EOSC platform in production.
To be customizable and scalable, all developments should be tested against 2-3 real life use cases from a variety of scientific domains. The proposals should cooperate with the EOSC Testbed facility (to be funded under HORIZON-INFRA-2023-EOSC-01-04) as well as other relevant and related projects and e-Infrastructures and large user communities. Joint use cases and testing across individual project boundaries are encouraged.
View this resource Bookmark this resourceParticipants are invited to submit COST Action proposals contributing to the scientific, technological, economic, cultural or societal knowledge advancement and development of Europe. Multi- and interdisciplinary proposals are encouraged.
The Open Call Action proposal submission, evaluation, selection and approval (SESA) procedure is fully science and technology-driven and will ensure a simple, transparent and competitive proposal evaluation and selection process, reflecting the bottom-up, open and inclusive principles of COST.
Participants planning to submit a proposal for a COST Action will need to refer to the SESA guidelines and to the Open Call Announcement available on the Documents and Guidelines page.
View this resource Bookmark this resourceThe Innovative Health Initiative Joint Undertaking (IHI JU) is a partnership between the European Union
and industry associations representing the sectors involved in healthcare, namely COCIR (medical
imaging, radiotherapy, health ICT and electromedical industries); EFPIA, including Vaccines Europe
(pharmaceutical industry and vaccine industry); EuropaBio (biotechnology industry); and MedTech
Europe (medical technology industry).
IHI JU aims to pioneer a new, more integrated approach to health research and builds on the experience
gained from the Innovative Medicine Initiative 2 Joint Undertaking (IMI2 JU).
IHI JU aims to translate health research and innovation into real benefits for patients and society, and
ensure that Europe remains at the cutting edge of interdisciplinary, sustainable, patient-centric health
research. Health research and care increasingly involve diverse sectors. By supporting projects that bring
these sectors together, IHI JU will pave the way for a more integrated approach to health care, covering
prevention, diagnosis, treatment, and disease management.
As current health challenges and threats are global, IHI JU should be open to participation by
international academic, industrial and regulatory actors, in order to benefit from wider access to data and
expertise, to respond to emerging health threats and to achieve the necessary societal impact, in
particular improved health outcomes for Union citizens
The Innovative Health Initiative Joint Undertaking (IHI JU) is a partnership between the European Union
and industry associations representing the sectors involved in healthcare, namely COCIR (medical
imaging, radiotherapy, health ICT and electromedical industries); EFPIA, including Vaccines Europe
(pharmaceutical industry and vaccine industry); EuropaBio (biotechnology industry); and MedTech
Europe (medical technology industry).
IHI JU aims to pioneer a new, more integrated approach to health research and builds on the experience
gained from the Innovative Medicine Initiative 2 Joint Undertaking (IMI2 JU).
IHI JU aims to translate health research and innovation into real benefits for patients and society, and
ensure that Europe remains at the cutting edge of interdisciplinary, sustainable, patient-centric health
research. Health research and care increasingly involve diverse sectors. By supporting projects that bring
these sectors together, IHI JU will pave the way for a more integrated approach to health care, covering
prevention, diagnosis, treatment, and disease management.
As current health challenges and threats are global, IHI JU should be open to participation by
international academic, industrial and regulatory actors, in order to benefit from wider access to data and
expertise, to respond to emerging health threats and to achieve the necessary societal impact, in
particular improved health outcomes for Union citizens.
The Public Involvement Starter grant is specifically aimed at supporting researchers to begin actively involving patients and the public in their research.
View this resource Bookmark this resourceThe Public Involvement Starter grant, is specifically aimed at supporting PhD researchers to begin actively involving patients and the public in their research.
View this resource Bookmark this resource